Last updated: June 17, 2024
Sponsor: Institut de Recherche pour le Developpement
Overall Status: Active - Recruiting
Phase
N/A
Condition
Sexually Transmitted Diseases (Stds)
Rash
Hepatitis B
Treatment
TRI-MOM intervention
Clinical Study ID
NCT05951751
IRD_2023_SESSTIM_TRI-MOM
Female Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Women attending a postnatal visit in one of the selected maternities (no maternalage limit)
Exclusion
Exclusion Criteria:
Refusal to participate in the study
Unable to provide consent
Study Design
Total Participants: 2800
Treatment Group(s): 1
Primary Treatment: TRI-MOM intervention
Phase:
Study Start date:
March 18, 2024
Estimated Completion Date:
May 31, 2025
Study Description
Connect with a study center
Centre Muraz/INSP
Bobo-Dioulasso,
Burkina FasoSite Not Available
MRC The Gambia at LSHTM
Fajara,
GambiaActive - Recruiting

Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.